Association of 3 gene polymorphisms with atopic diseases

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 4, 1999, Pages 702-708

  Hollá, Lydie ^a   Vasků, Anna ^b   Znojil, Vladimír ^b   Šišková, Lenka ^b   Vácha, Jirí ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b NONE

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Asthma bronchiale; Atopy; Endothelin 1; Enzymes; Genes; Polymorphism

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN; PEPTIDASE; PEPTIDE;

ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHOSPASM; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; INFLAMMATION; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RHINITIS;

EID: 0032983648     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70246-0     Document Type: Article

References (51)

1. 1. Sandford A, Weir T, Pare P. Genetics of asthma. Am J Respir Crit Care Med 1996:153:1749-65.
2. 2. Aberg N. Familial occurrence of atopic disease: genetic versus environmental factors. Clin Exp Allergy 1993;23:829-34.
3. 3. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
4. 4. Bonini S. Bronchial asthma: No more doubts? Allergy 1996;51:203-5.
5. 5. Holgate ST. Cournand Lecture. Asthma: past, present and future. Eur Respir J 1993;6:1507-20.
6. 6. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.
7. 7. Jan Danser AH, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GA, et al. ACE in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-8.
8. 8. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
9. 9. Riggat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
10. 10. Cambien F, Costerousse O, Tiret L, Lecerf L, Gonzales MF, Evans A, et al. Plasma level and gene polymorphism of the angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-76.
11. 11. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene association with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-202.
12. 12. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
13. 13. Brasier AR, Ron D, Tale JE, Habener JF. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 α induced, NFkB mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J 1990;9:3933-44.
14. 14. Ron D, Brasier AR, Habener JF. Angiotensinogen gene-inducible enhancer-binding protein 1, a member of a new family of large nuclear proteins that recognize nuclear factor ΚB-binding sites through a zinc finger motif. Mol Cell Biol 1991;11:2887-95.
15. 15. Ron D, Brasier AR, Wrihgt KA, Habener JF. The permissive role of glucocorticoids on interleukin-I stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol Cell Biol 1990;10:4389-95.
16. 16. Wintroub BU, Klickstein LB, Dzau VJ, Watt KWK. Granulocyte-angiotensin system: identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry 1984;23:227-32.
17. 17. Padgett RC, Vasquez R, Brooks RM, Heistad DD. Human leukocytes release angiotensin II [abstract]. Hypertension 1992;20:408A.
18. 18. Lazzarini-Robertson A, Khairallah PA. Effects of angiotensin II and some analogues on vascular permeability in the rabbit. Circ Res 1972;31:923-31.
19. 19. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
20. 20. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, et al. Angiotensin 2 stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991;9:17-22.
21. 21. Daeman MJAP, Lanbardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6.
22. 22. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-I gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992;19:753.
23. 23. Yanagisawa M, Kurihara S, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
24. 24. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995;25:1135-45.
25. 25. Hahn AWA, Resink TJ, Scott-Burden T, Powell J, Dohi Y Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1990;1:649-59.
26. 26. Yu JCM, Davenport AP. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol 1995;114:551-7.
27. 27. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
28. 28. Suzuki N, Matsumoto H, Kitada C, Kimura S, Fujino M. Production of endothelin-1 and big-endothelin-1 by tumor cells with epithelial-like morphology. J Biochem 1989;106:736-41.
29. 29. Giaid A, Hamid QA, Springall DR, Yanagisawa M, Shinmi O, Sawamura T, et al. Detection of endothelin immunoreactivity and mRNA in pulmonary tumors. J Pathol 1990;162:15-22.
30. 30. Saenz de Tejada I, Mueller JD, De Las Morenas A, Machado M, Moreland RB, Krane RJ, et al. Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, smooth muscle and fibroblasts suggests autocrine and paracrine cellular regulation. J Urol 1992;148:1290-8.
31. 31. Ferris BJ. Epidemiology standardization project. Am Rev Respir Dis 1978;118(Suppl):1-88.
32. 32. American Thoracic Society. Definition and classification of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 1962;85:762-8.
33. 33. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92:44-7.
34. 34. Riggat B, Hubert C, Corvol P, Soubrier F, PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
35. 35. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods and Applications 1993;3:120-1.
36. 36. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.
37. 37. Benessiano J, Crestani B, Mestari F, Klouche W, Neukirch F, Hacein-Bey S, et al. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol 1997;99:53-7.
38. 38. Johnson AR, Ashton J, Schulz WW, Erdös EG. Neutral melalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985;132:564-8.
39. 39. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986;78:31-9.
40. 40. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
41. 41. Vuk PZ, Kreofsky TJ, Rohrbach MS. Characteristics of monocyte angiotensin-converting enzyme (ACE) induction by dexamethasone. J Leukoc Biol 1989;45:503-9.
42. 42. Naftilan AJ, Pratt RF, Dzau VJ. Induction of platelet derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-24.
43. 43. Shindler R, Dinarello CA, Koch KM. Angiotensin-converting enzyme inhibitors suppress synthesis of tumor necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine 1995;7:526-33.
44. 44. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
45. 45. Rubanyi GM, Parker-Botelho LH. Endothelins. FASEB J 1991;5:2713-20.
46. 46. Uemam J, Munemura C, Fujihara M, Kawasaki H. Inhibition of plasma endothelin-1 concentration by captopril in patients with essential hypertension. Clin Nephrol 1994;41:150-2.
47. 47. Haynes WG, Web DJ. The endothelin family of peptides: Local hormones with diverse roles in health and discase? Clin Sci 1993;84:485-500.
48. 48. Sporn MB, Roberts AB. Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest 1986;78:329-32.
49. 49. Simonson MS, Dunn MJ. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J Lab Clin Med 1992;119:622-39.
50. 50. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172:1741-8.
51. 51. Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 174:613-8.